Does this gap in valuation between Abbott and its peers make sense? We don’t think so, especially if we look at the fundamentals of these companies. More specifically, we arrive at our conclusion by looking at historical trends in revenues, operating income, and market cap-to-operating income ratio for these companies. Our dashboard1. Revenue Growth
Abbott has benefited from Covid-19 testing, which offset the decline seen in other businesses, including medical devices, due to the deferment of elective surgeries.
I just moved to your city, who wouldn't mind showing me interesting places?